IMVT-1402 is a next-generation anti-FcRn monoclonal antibody designed to bind to the FcRn receptor and prevent IgG recycling which has been studied in both healthy patients and patients with autoimmune diseases [92]. The gene discussed is FCGRT; the disease is autoimmune disease.